Kyle Jenne - EVP, Chf GL Pdt Str Ofcr at IONIS PHARMACEUTICALS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chf GL Pdt Str Ofcr
Issuer Symbol
IONS on Nasdaq
All Insider Reports
All Insider Reports

Kyle Jenne - trading volume in the past year for IONIS PHARMACEUTICALS INC

Holdings reported by Kyle Jenne for IONIS PHARMACEUTICALS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 16,389 $1,244,908 $75.96 16 Jan 2026 Direct
Restricted Stock Unit 29,664 $1,185,401 $32.32 15 Jan 2026 Direct Common Stock
Performance Restricted Stock Units 44,500 $613,472 $32.81 15 Jan 2026 Direct Common Stock
Non-Qualified Stock Option (right to buy) 19,350 02 Jan 2026 Direct Common Stock

Transactions reported by Kyle Jenne for IONIS PHARMACEUTICALS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.